25 XP   0   0   10

Axogen Inc
Buy, Hold or Sell?

Let's analyse Axogen Inc together

PenkeI guess you are interested in Axogen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Axogen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Axogen Inc

I send you an email if I find something interesting about Axogen Inc.

Quick analysis of Axogen Inc (30 sec.)










What can you expect buying and holding a share of Axogen Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$2.21
Expected worth in 1 year
$2.09
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.12
Return On Investment
-1.9%

For what price can you sell your share?

Current Price per Share
$6.50
Expected price per share
$4.71 - $9.45
How sure are you?
50%

1. Valuation of Axogen Inc (5 min.)




Live pricePrice per Share (EOD)

$6.50

Intrinsic Value Per Share

$-7.44 - $-4.37

Total Value Per Share

$-5.22 - $-2.16

2. Growth of Axogen Inc (5 min.)




Is Axogen Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$95.6m$101.9m-$4.9m-5.1%

How much money is Axogen Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.3m-$6.8m$1.4m28.0%
Net Profit Margin-13.7%-20.4%--

How much money comes from the company's main activities?

3. Financial Health of Axogen Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#145 / 339

Most Revenue
#125 / 339

Most Profit
#230 / 339

Most Efficient
#167 / 339

What can you expect buying and holding a share of Axogen Inc? (5 min.)

Welcome investor! Axogen Inc's management wants to use your money to grow the business. In return you get a share of Axogen Inc.

What can you expect buying and holding a share of Axogen Inc?

First you should know what it really means to hold a share of Axogen Inc. And how you can make/lose money.

Speculation

The Price per Share of Axogen Inc is $6.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Axogen Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Axogen Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.21. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Axogen Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-1.4%-0.13-1.9%-0.17-2.6%-0.15-2.3%-0.12-1.9%
Usd Book Value Change Per Share-0.05-0.8%-0.03-0.5%-0.07-1.0%-0.06-0.9%0.060.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.000.1%
Usd Total Gains Per Share-0.05-0.8%-0.03-0.5%-0.07-1.0%-0.05-0.8%0.060.9%
Usd Price Per Share6.83-7.60-9.51-12.79-13.32-
Price to Earnings Ratio-18.95--15.35--17.16--24.23--32.21-
Price-to-Total Gains Ratio-137.57--254.78--818.03--326.15--292.43-
Price to Book Ratio3.08-3.39-4.03-4.71-16.65-
Price-to-Total Gains Ratio-137.57--254.78--818.03--326.15--292.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.5
Number of shares153
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.03-0.06
Usd Total Gains Per Share-0.03-0.05
Gains per Quarter (153 shares)-4.72-7.88
Gains per Year (153 shares)-18.89-31.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-19-295-36-42
20-38-4810-73-74
30-57-6714-109-106
40-76-8619-145-138
50-94-10524-182-170
60-113-12429-218-202
70-132-14334-254-234
80-151-16239-291-266
90-170-18143-327-298
100-189-20048-363-330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%31.0100.07.022.5%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%8.032.00.020.0%41.090.07.029.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.039.02.5%4.00.0134.02.9%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.017.00.015.0%8.032.00.020.0%44.088.06.031.9%

Fundamentals of Axogen Inc

About Axogen Inc

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Fundamental data was last updated by Penke on 2024-04-11 01:39:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Axogen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Axogen Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Axogen Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -9.1% means that $-0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Axogen Inc:

  • The MRQ is -9.1%. The company is making a loss. -1
  • The TTM is -13.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-13.7%+4.6%
TTM-13.7%YOY-20.4%+6.7%
TTM-13.7%5Y-21.3%+7.6%
5Y-21.3%10Y-34.6%+13.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-11.2%+2.1%
TTM-13.7%-19.6%+5.9%
YOY-20.4%-14.4%-6.0%
5Y-21.3%-21.3%+0.0%
10Y-34.6%-24.8%-9.8%
1.1.2. Return on Assets

Shows how efficient Axogen Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Axogen Inc to the Medical Devices industry mean.
  • -2.0% Return on Assets means that Axogen Inc generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Axogen Inc:

  • The MRQ is -2.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-2.8%+0.8%
TTM-2.8%YOY-3.5%+0.7%
TTM-2.8%5Y-3.5%+0.8%
5Y-3.5%10Y-7.1%+3.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%-4.0%+2.0%
TTM-2.8%-4.5%+1.7%
YOY-3.5%-4.8%+1.3%
5Y-3.5%-4.0%+0.5%
10Y-7.1%-4.9%-2.2%
1.1.3. Return on Equity

Shows how efficient Axogen Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Axogen Inc to the Medical Devices industry mean.
  • -4.1% Return on Equity means Axogen Inc generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Axogen Inc:

  • The MRQ is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-5.5%+1.4%
TTM-5.5%YOY-6.7%+1.2%
TTM-5.5%5Y-5.6%+0.1%
5Y-5.6%10Y-18.1%+12.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%-3.9%-0.2%
TTM-5.5%-5.6%+0.1%
YOY-6.7%-5.9%-0.8%
5Y-5.6%-6.1%+0.5%
10Y-18.1%-7.0%-11.1%

1.2. Operating Efficiency of Axogen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Axogen Inc is operating .

  • Measures how much profit Axogen Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Axogen Inc to the Medical Devices industry mean.
  • An Operating Margin of -7.4% means the company generated $-0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Axogen Inc:

  • The MRQ is -7.4%. The company is operating very inefficient. -2
  • The TTM is -14.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7.4%TTM-14.0%+6.6%
TTM-14.0%YOY-22.0%+8.0%
TTM-14.0%5Y-22.0%+8.0%
5Y-22.0%10Y-26.7%+4.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.4%-24.1%+16.7%
TTM-14.0%-16.9%+2.9%
YOY-22.0%-13.4%-8.6%
5Y-22.0%-19.2%-2.8%
10Y-26.7%-24.0%-2.7%
1.2.2. Operating Ratio

Measures how efficient Axogen Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.07 means that the operating costs are $1.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Axogen Inc:

  • The MRQ is 1.074. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.138. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.074TTM1.138-0.064
TTM1.138YOY1.220-0.082
TTM1.1385Y1.218-0.080
5Y1.21810Y1.265-0.047
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0741.431-0.357
TTM1.1381.426-0.288
YOY1.2201.503-0.283
5Y1.2181.440-0.222
10Y1.2651.371-0.106

1.3. Liquidity of Axogen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Axogen Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.89 means the company has $2.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Axogen Inc:

  • The MRQ is 2.892. The company is able to pay all its short-term debts. +1
  • The TTM is 3.488. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.892TTM3.488-0.596
TTM3.488YOY4.477-0.989
TTM3.4885Y5.884-2.396
5Y5.88410Y6.777-0.893
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8922.754+0.138
TTM3.4882.763+0.725
YOY4.4773.488+0.989
5Y5.8843.617+2.267
10Y6.7773.514+3.263
1.3.2. Quick Ratio

Measures if Axogen Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Axogen Inc to the Medical Devices industry mean.
  • A Quick Ratio of 2.04 means the company can pay off $2.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Axogen Inc:

  • The MRQ is 2.043. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.816. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.043TTM2.816-0.773
TTM2.816YOY5.135-2.319
TTM2.8165Y6.872-4.056
5Y6.87210Y7.105-0.234
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0431.532+0.511
TTM2.8161.656+1.160
YOY5.1352.139+2.996
5Y6.8722.301+4.571
10Y7.1052.255+4.850

1.4. Solvency of Axogen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Axogen Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Axogen Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.51 means that Axogen Inc assets are financed with 51.4% credit (debt) and the remaining percentage (100% - 51.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Axogen Inc:

  • The MRQ is 0.514. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.497. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.497+0.017
TTM0.497YOY0.480+0.017
TTM0.4975Y0.368+0.130
5Y0.36810Y0.593-0.225
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5140.389+0.125
TTM0.4970.386+0.111
YOY0.4800.338+0.142
5Y0.3680.442-0.074
10Y0.5930.460+0.133
1.4.2. Debt to Equity Ratio

Measures if Axogen Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Axogen Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 105.7% means that company has $1.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Axogen Inc:

  • The MRQ is 1.057. The company is able to pay all its debts with equity. +1
  • The TTM is 0.991. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.057TTM0.991+0.067
TTM0.991YOY0.924+0.067
TTM0.9915Y0.658+0.333
5Y0.65810Y1.904-1.246
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0570.559+0.498
TTM0.9910.560+0.431
YOY0.9240.478+0.446
5Y0.6580.624+0.034
10Y1.9040.674+1.230

2. Market Valuation of Axogen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Axogen Inc generates.

  • Above 15 is considered overpriced but always compare Axogen Inc to the Medical Devices industry mean.
  • A PE ratio of -18.95 means the investor is paying $-18.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Axogen Inc:

  • The EOD is -18.035. Based on the earnings, the company is expensive. -2
  • The MRQ is -18.951. Based on the earnings, the company is expensive. -2
  • The TTM is -15.349. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.035MRQ-18.951+0.916
MRQ-18.951TTM-15.349-3.602
TTM-15.349YOY-17.157+1.808
TTM-15.3495Y-24.233+8.884
5Y-24.23310Y-32.207+7.974
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-18.035-0.997-17.038
MRQ-18.951-1.578-17.373
TTM-15.349-2.041-13.308
YOY-17.157-2.761-14.396
5Y-24.233-2.064-22.169
10Y-32.207-1.463-30.744
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Axogen Inc:

  • The EOD is -35.317. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -37.110. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -22.951. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-35.317MRQ-37.110+1.793
MRQ-37.110TTM-22.951-14.159
TTM-22.951YOY-14.629-8.322
TTM-22.9515Y-41.236+18.286
5Y-41.23610Y-42.735+1.499
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-35.317-0.935-34.382
MRQ-37.110-1.489-35.621
TTM-22.951-2.994-19.957
YOY-14.629-6.238-8.391
5Y-41.236-4.771-36.465
10Y-42.735-4.736-37.999
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Axogen Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.08 means the investor is paying $3.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Axogen Inc:

  • The EOD is 2.936. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.085. Based on the equity, the company is fair priced.
  • The TTM is 3.385. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.936MRQ3.085-0.149
MRQ3.085TTM3.385-0.301
TTM3.385YOY4.032-0.647
TTM3.3855Y4.711-1.326
5Y4.71110Y16.649-11.938
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.9361.890+1.046
MRQ3.0852.379+0.706
TTM3.3852.458+0.927
YOY4.0323.214+0.818
5Y4.7113.833+0.878
10Y16.6494.173+12.476
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Axogen Inc.

3.1. Institutions holding Axogen Inc

Institutions are holding 77.913% of the shares of Axogen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)11.94750.3884515230059742013.116
2023-12-31BlackRock Inc7.75140.00063342773983293.0307
2023-12-31Morgan Stanley - Brokerage Accounts7.14780.001930824372702067710.3786
2023-12-31Soleus Capital Management, L.P.6.01941.96722595815-1190014-31.4334
2023-12-31Vanguard Group Inc5.71720.00042465496-13025-0.5255
2023-12-31Millennium Management LLC3.45210.00441488720-104543-6.5616
2023-12-31Goldman Sachs Group Inc2.36160.000610184289446951281.2377
2023-12-31Dafna Capital Management LLC2.17021.531693589400
2023-12-31Geode Capital Management, LLC2.07850.0006896336475935.6075
2023-12-31Perceptive Advisors LLC1.87450.1232808380-67518-7.7084
2023-12-31State Street Corporation1.83670.0003792087297493.9023
2023-12-31Tocqueville Asset Management L.P.1.78530.0953769900-165000-17.6489
2023-12-31Silvercrest Asset Management Group LLC1.75360.0365756248-165738-17.9762
2023-12-31Dimensional Fund Advisors, Inc.1.34320.0012579266-24877-4.1177
2023-12-31Deutsche Bank AG1.34180.0025786405529992156.6983
2023-09-30D. E. Shaw & Co LP1.33440.003575445-139357-19.4959
2023-12-31Bank of America Corp1.20980.0004521715-1195457-69.6178
2023-12-31Northern Trust Corp0.88650.0005382292-24292-5.9747
2023-12-31Nuveen Asset Management, LLC0.81890.000835313616531088.0123
2023-12-31Charles Schwab Investment Management Inc0.76830.0006331313212376.849
Total 63.59874.159527426621+2069578+7.5%

3.2. Funds holding Axogen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Explorer Inv3.6120.0504157798317887112.7846
2024-02-29Vanguard Total Stock Mkt Idx Inv2.93880.00091283895-91700-6.6662
2024-01-31Strategic Advisers Small-Mid Cap2.30760.10891008133-87966-8.0254
2024-03-28iShares Russell 2000 ETF2.30520.012410070884860.0483
2023-12-31Meridian Growth Legacy1.5440.333867452500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.47120.006764271773931.1637
2023-12-31Vanguard VIF Small Co Gr1.20240.2373525314396138.1558
2024-01-31Fidelity Small Cap Index0.94350.016141218252431.2884
2023-12-31Meridian Small Cap Growth Legacy0.84020.396936708200
2023-12-31ArrowMark Small Cap Gro0.84020.398836708200
2024-03-28iShares Russell 2000 Growth ETF0.82280.0249359464-418-0.1161
2023-12-31Kennedy Micro Cap0.68450.4309299037-5220-1.7157
2024-03-28iShares US Medical Devices ETF0.67710.041429582200
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.58120.006425390249001.9679
2024-02-29Fidelity Extended Market Index0.57380.0069250681113914.7603
2024-01-31CREF Stock R10.57270.002125021000
2023-12-31Silvercrest U.S. Small Cap Growth0.56580.8568247164-55155-18.244
2024-03-29Schwab US Small-Cap ETF™0.46970.009720522300
2024-02-29DFA US Small Cap I0.38710.0115169127103096.4911
2024-02-29Vanguard Russell 2000 ETF0.34080.0165148884116498.4884
Total 23.68062.969310345515+29396+0.3%

3.3. Insider Transactions

Insiders are holding 5.747% of the shares of Axogen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-21Erick Wayne DevinneySELL45787.68
2024-03-21Karen L ZaderejSELL392807.68
2024-03-21Michael Patrick DonovanSELL60337.68
2024-03-07Gregory Gene FreitagSELL250009
2024-03-07Michael Patrick DonovanSELL363108.81
2023-12-11Peter J MarianiSELL125007.5
2023-09-06Amy Mcbride WendellBUY100006.22
2023-08-23William P Mr. BurkeBUY100006.56
2023-08-16Guido J NeelsBUY100006.11
2023-06-01Gregory Gene FreitagSELL419808.71

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Axogen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.050-0.031-38%-0.067+35%-0.059+20%0.055-190%
Book Value Per Share--2.2142.246-1%2.361-6%2.659-17%1.639+35%
Current Ratio--2.8923.488-17%4.477-35%5.884-51%6.777-57%
Debt To Asset Ratio--0.5140.497+3%0.480+7%0.368+40%0.593-13%
Debt To Equity Ratio--1.0570.991+7%0.924+14%0.658+61%1.904-44%
Dividend Per Share----0%-0%0.008-100%0.004-100%
Eps---0.090-0.126+39%-0.167+86%-0.151+68%-0.121+34%
Free Cash Flow Per Share---0.046-0.119+159%-0.216+369%-0.182+295%-0.133+188%
Free Cash Flow To Equity Per Share---0.036-0.108+197%-0.206+466%-0.102+181%0.008-567%
Gross Profit Margin--6.6965.322+26%4.459+50%4.586+46%3.890+72%
Intrinsic Value_10Y_max---4.370--------
Intrinsic Value_10Y_min---7.437--------
Intrinsic Value_1Y_max---0.518--------
Intrinsic Value_1Y_min---0.770--------
Intrinsic Value_3Y_max---1.495--------
Intrinsic Value_3Y_min---2.307--------
Intrinsic Value_5Y_max---2.398--------
Intrinsic Value_5Y_min---3.822--------
Market Cap280840300.000-5%295098346.000328475135.500-10%410782946.500-28%552780122.800-47%575344560.750-49%
Net Profit Margin---0.091-0.137+51%-0.204+125%-0.213+135%-0.346+281%
Operating Margin---0.074-0.140+88%-0.220+196%-0.220+196%-0.267+259%
Operating Ratio--1.0741.138-6%1.220-12%1.218-12%1.265-15%
Pb Ratio2.936-5%3.0853.385-9%4.032-24%4.711-35%16.649-81%
Pe Ratio-18.035+5%-18.951-15.349-19%-17.157-9%-24.233+28%-32.207+70%
Price Per Share6.500-5%6.8307.603-10%9.508-28%12.794-47%13.316-49%
Price To Free Cash Flow Ratio-35.317+5%-37.110-22.951-38%-14.629-61%-41.236+11%-42.735+15%
Price To Total Gains Ratio-130.928+5%-137.575-254.777+85%-818.027+495%-326.154+137%-292.432+113%
Quick Ratio--2.0432.816-27%5.135-60%6.872-70%7.105-71%
Return On Assets---0.020-0.028+40%-0.035+76%-0.035+79%-0.071+261%
Return On Equity---0.041-0.055+35%-0.067+64%-0.056+38%-0.181+344%
Total Gains Per Share---0.050-0.031-38%-0.067+35%-0.052+4%0.059-184%
Usd Book Value--95665000.00097035000.000-1%101996250.000-6%114872300.000-17%70794677.550+35%
Usd Book Value Change Per Share---0.050-0.031-38%-0.067+35%-0.059+20%0.055-190%
Usd Book Value Per Share--2.2142.246-1%2.361-6%2.659-17%1.639+35%
Usd Dividend Per Share----0%-0%0.008-100%0.004-100%
Usd Eps---0.090-0.126+39%-0.167+86%-0.151+68%-0.121+34%
Usd Free Cash Flow---1988000.000-5158500.000+159%-9329750.000+369%-7853950.000+295%-5728006.425+188%
Usd Free Cash Flow Per Share---0.046-0.119+159%-0.216+369%-0.182+295%-0.133+188%
Usd Free Cash Flow To Equity Per Share---0.036-0.108+197%-0.206+466%-0.102+181%0.008-567%
Usd Market Cap280840300.000-5%295098346.000328475135.500-10%410782946.500-28%552780122.800-47%575344560.750-49%
Usd Price Per Share6.500-5%6.8307.603-10%9.508-28%12.794-47%13.316-49%
Usd Profit---3893000.000-5338000.000+37%-6833750.000+76%-6429700.000+65%-5172728.300+33%
Usd Revenue--42922000.00039753000.000+8%34646000.000+24%32198300.000+33%21839648.100+97%
Usd Total Gains Per Share---0.050-0.031-38%-0.067+35%-0.052+4%0.059-184%
 EOD+3 -5MRQTTM+20 -14YOY+24 -105Y+22 -1410Y+21 -15

4.2. Fundamental Score

Let's check the fundamental score of Axogen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-18.035
Price to Book Ratio (EOD)Between0-12.936
Net Profit Margin (MRQ)Greater than0-0.091
Operating Margin (MRQ)Greater than0-0.074
Quick Ratio (MRQ)Greater than12.043
Current Ratio (MRQ)Greater than12.892
Debt to Asset Ratio (MRQ)Less than10.514
Debt to Equity Ratio (MRQ)Less than11.057
Return on Equity (MRQ)Greater than0.15-0.041
Return on Assets (MRQ)Greater than0.05-0.020
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Axogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.450
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net 19374267123390373763-1,462-699



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets196,827
Total Liabilities101,162
Total Stockholder Equity95,665
 As reported
Total Liabilities 101,162
Total Stockholder Equity+ 95,665
Total Assets = 196,827

Assets

Total Assets196,827
Total Current Assets88,004
Long-term Assets108,823
Total Current Assets
Cash And Cash Equivalents 37,026
Net Receivables 25,147
Inventory 23,020
Other Current Assets 2,811
Total Current Assets  (as reported)88,004
Total Current Assets  (calculated)88,004
+/-0
Long-term Assets
Property Plant Equipment 104,292
Intangible Assets 4,531
Long-term Assets  (as reported)108,823
Long-term Assets  (calculated)108,823
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities30,430
Long-term Liabilities70,732
Total Stockholder Equity95,665
Total Current Liabilities
Short-term Debt 1,547
Accounts payable 28,883
Total Current Liabilities  (as reported)30,430
Total Current Liabilities  (calculated)30,430
+/-0
Long-term Liabilities
Long term Debt 46,603
Capital Lease Obligations 22,689
Long-term Liabilities  (as reported)70,732
Long-term Liabilities  (calculated)69,292
+/- 1,440
Total Stockholder Equity
Common Stock431
Retained Earnings -281,296
Other Stockholders Equity 376,530
Total Stockholder Equity (as reported)95,665
Total Stockholder Equity (calculated)95,665
+/-0
Other
Capital Stock431
Cash and Short Term Investments 37,026
Common Stock Shares Outstanding 43,048
Liabilities and Stockholders Equity 196,827
Net Debt 32,266
Net Invested Capital 142,268
Net Working Capital 57,574
Property Plant and Equipment Gross 117,989
Short Long Term Debt Total 69,292



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-311986-12-311986-09-30
> Total Assets 
0
0
0
6,700
0
0
0
6,900
0
0
0
8,200
8,500
58,200
57,500
8,400
8,300
8,400
9,000
8,400
9,000
9,500
9,800
9,900
10,400
10,400
10,900
11,000
11,900
12,200
12,000
12,400
12,600
12,700
12,900
12,700
12,900
12,400
12,600
12,300
12,400
12,300
11,600
11,800
12,400
12,300
12,000
11,300
11,200
10,600
10,300
10,100
9,600
8,800
9,436
8,475
8,234
8,360
7,682
9,968
8,086
6,600
5,644
5,218
4,642
4,150
4,150
3,055
2,762
2,691
2,463
2,414
3,739
2,803
2,803
1,785
1,749
1,825
1,791
1,701
1,620
1,515
1,436
1,237
1,132
1,100
1,100
795
642
524
436
735
456
16,808
11,322
10,787
10,405
10,143
11,371
12,161
14,441
12,495
10,477
9,838
9,694
20,231
17,852
15,673
29,764
27,684
24,568
22,399
20,097
16,401
28,136
25,423
40,913
37,546
33,497
31,751
30,773
46,360
43,273
42,766
42,228
58,875
55,171
160,544
161,658
160,173
160,492
156,603
154,192
154,643
144,883
169,961
193,937
201,381
197,369
210,532
209,971
208,024
198,025
196,084
195,520
195,387
189,474
191,641
194,630
196,827
196,827194,630191,641189,474195,387195,520196,084198,025208,024209,971210,532197,369201,381193,937169,961144,883154,643154,192156,603160,492160,173161,658160,54455,17158,87542,22842,76643,27346,36030,77331,75133,49737,54640,91325,42328,13616,40120,09722,39924,56827,68429,76415,67317,85220,2319,6949,83810,47712,49514,44112,16111,37110,14310,40510,78711,32216,8084567354365246427951,1001,1001,1321,2371,4361,5151,6201,7011,7911,8251,7491,7852,8032,8033,7392,4142,4632,6912,7623,0554,1504,1504,6425,2185,6446,6008,0869,9687,6828,3608,2348,4759,4368,8009,60010,10010,30010,60011,20011,30012,00012,30012,40011,80011,60012,30012,40012,30012,60012,40012,90012,70012,90012,70012,60012,40012,00012,20011,90011,00010,90010,40010,4009,9009,8009,5009,0008,4009,0008,4008,3008,40057,50058,2008,5008,2000006,9000006,700000
   > Total Current Assets 
0
0
0
2,400
0
0
0
2,800
0
0
0
3,500
3,600
12,200
11,400
4,500
4,500
4,400
4,800
4,300
4,800
5,300
5,500
5,500
5,900
5,800
6,200
6,100
6,900
6,900
6,900
6,100
6,300
5,900
6,000
5,800
6,100
5,100
5,600
5,400
5,700
5,800
5,900
6,900
7,400
7,500
7,200
6,700
6,800
6,200
6,100
5,900
5,500
4,700
5,512
5,236
5,009
5,180
5,031
7,301
5,480
4,000
3,208
2,920
2,469
2,114
2,114
2,198
1,965
2,002
1,834
1,801
3,195
2,570
2,570
1,581
1,500
1,592
1,575
1,502
1,437
1,348
1,286
1,103
1,013
996
996
700
555
454
383
691
417
16,773
11,283
10,753
10,353
10,087
11,320
9,593
13,071
10,882
8,805
8,209
8,183
18,296
15,942
13,811
27,964
25,659
22,434
20,253
17,993
14,411
26,015
23,242
38,570
35,051
31,454
29,747
28,665
44,037
40,898
40,182
39,513
55,741
51,735
156,910
152,786
150,953
145,629
141,292
137,343
135,021
120,352
140,229
139,973
145,251
135,145
141,795
134,968
127,049
112,475
106,775
102,454
98,075
88,699
86,176
87,439
88,004
88,00487,43986,17688,69998,075102,454106,775112,475127,049134,968141,795135,145145,251139,973140,229120,352135,021137,343141,292145,629150,953152,786156,91051,73555,74139,51340,18240,89844,03728,66529,74731,45435,05138,57023,24226,01514,41117,99320,25322,43425,65927,96413,81115,94218,2968,1838,2098,80510,88213,0719,59311,32010,08710,35310,75311,28316,7734176913834545557009969961,0131,1031,2861,3481,4371,5021,5751,5921,5001,5812,5702,5703,1951,8011,8342,0021,9652,1982,1142,1142,4692,9203,2084,0005,4807,3015,0315,1805,0095,2365,5124,7005,5005,9006,1006,2006,8006,7007,2007,5007,4006,9005,9005,8005,7005,4005,6005,1006,1005,8006,0005,9006,3006,1006,9006,9006,9006,1006,2005,8005,9005,5005,5005,3004,8004,3004,8004,4004,5004,50011,40012,2003,6003,5000002,8000002,400000
       Cash And Cash Equivalents 
0
0
0
1,000
0
0
0
800
0
0
0
1,200
1,100
1,100
1,000
600
700
500
400
500
300
100
600
1,500
400
200
800
400
400
100
400
800
400
800
700
800
400
500
200
800
400
600
500
700
600
1,600
1,600
2,200
2,000
1,000
900
1,000
500
0
36
100
70
286
48
3,377
1,943
1,400
389
672
537
672
672
411
366
484
734
892
2,110
2,239
2,239
1,478
1,355
1,311
1,430
1,446
1,362
1,282
1,228
1,054
943
833
833
589
410
333
242
211
227
15,766
10,180
9,634
9,284
7,077
5,641
9,555
10,526
8,191
5,642
4,639
4,445
13,907
11,200
8,693
22,586
20,070
16,808
14,170
11,803
8,216
19,256
15,623
29,935
25,910
20,949
18,273
16,003
30,014
25,914
23,870
22,041
36,507
30,560
133,562
25,629
24,294
23,522
24,878
24,555
35,724
35,894
75,320
60,002
48,767
39,843
53,078
46,730
32,756
14,559
11,822
14,318
15,284
7,707
23,219
31,094
37,026
37,02631,09423,2197,70715,28414,31811,82214,55932,75646,73053,07839,84348,76760,00275,32035,89435,72424,55524,87823,52224,29425,629133,56230,56036,50722,04123,87025,91430,01416,00318,27320,94925,91029,93515,62319,2568,21611,80314,17016,80820,07022,5868,69311,20013,9074,4454,6395,6428,19110,5269,5555,6417,0779,2849,63410,18015,7662272112423334105898338339431,0541,2281,2821,3621,4461,4301,3111,3551,4782,2392,2392,1108927344843664116726725376723891,4001,9433,37748286701003605001,0009001,0002,0002,2001,6001,6006007005006004008002005004008007008004008004001004004008002004001,5006001003005004005007006001,0001,1001,1001,2000008000001,000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,740
92,311
84,323
78,185
75,511
60,786
47,145
24,009
39,126
55,199
51,062
46,839
44,989
51,330
52,859
46,210
38,792
33,505
30,160
11,312
1,494
0
01,49411,31230,16033,50538,79246,21052,85951,33044,98946,83951,06255,19939,12624,00947,14560,78675,51178,18584,32392,311100,74000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
900
0
0
0
1,200
0
0
0
1,500
1,600
5,200
5,100
1,700
1,300
1,500
1,600
1,600
1,500
1,400
1,500
1,400
1,600
1,500
1,700
1,600
2,200
1,800
2,200
2,100
3,000
2,100
2,600
2,400
2,300
2,200
2,900
2,100
2,300
2,300
2,500
2,600
3,300
2,800
3,400
2,300
2,300
2,700
2,700
2,400
2,200
2,000
2,541
2,646
2,235
2,190
2,385
1,578
1,185
800
934
677
281
319
319
181
73
204
100
1
0
0
81
39
70
215
89
0
0
0
0
0
0
100
100
9
14
33
75
408
124
32
20
3
26
42
2,477
19
538
798
894
862
926
1,050
1,179
1,416
1,740
1,894
1,965
2,527
2,743
2,872
3,162
3,838
4,643
4,783
5,291
6,072
7,005
8,052
8,384
9,422
10,201
11,065
11,767
12,359
13,990
15,321
15,193
16,285
15,549
16,944
13,020
14,049
18,781
17,618
19,862
18,626
18,645
18,158
18,590
20,370
21,363
22,186
22,278
21,573
23,263
25,147
25,14723,26321,57322,27822,18621,36320,37018,59018,15818,64518,62619,86217,61818,78114,04913,02016,94415,54916,28515,19315,32113,99012,35911,76711,06510,2019,4228,3848,0527,0056,0725,2914,7834,6433,8383,1622,8722,7432,5271,9651,8941,7401,4161,1791,050926862894798538192,477422632032124408753314910010000000089215703981001100204731813193192816779348001,1851,5782,3852,1902,2352,6462,5412,0002,2002,4002,7002,7002,3002,3003,4002,8003,3002,6002,5002,3002,3002,1002,9002,2002,3002,4002,6002,1003,0002,1002,2001,8002,2001,6001,7001,5001,6001,4001,5001,4001,5001,6001,6001,5001,3001,7005,1005,2001,6001,5000001,200000900000
       Other Current Assets 
0
0
0
0
0
0
0
100
0
0
0
0
0
0
0
1,100
1,300
1,300
1,600
1,200
1,900
2,400
1,800
1,300
2,300
2,600
2,300
3,200
3,100
3,500
2,700
1,400
400
600
400
500
1,000
300
400
500
800
500
500
1,000
900
600
500
500
700
600
600
500
700
600
588
243
299
411
366
294
1
0
271
212
127
113
113
261
198
221
222
72
1,036
0
193
1
75
67
55
57
75
66
57
49
70
0
63
102
131
89
66
72
66
975
1,084
1,116
1,043
1,960
3,184
19
345
134
142
241
90
187
142
127
177
297
195
145
101
109
260
241
290
425
699
616
686
512
749
585
572
853
1,355
1,307
1,477
1,045
3,471
2,357
8,046
1,706
9,730
3,405
10,135
4,296
10,990
9,837
9,151
1,861
2,816
2,900
2,614
1,944
2,453
2,583
2,567
2,811
2,8112,5672,5832,4531,9442,6142,9002,8161,8619,1519,83710,9904,29610,1353,4059,7301,7068,0462,3573,4711,0451,4771,3071,35585357258574951268661669942529024126010910114519529717712714218790241142134345193,1841,9601,0431,1161,08497566726689131102630704957667557556775119301,03672222221198261113113127212271012943664112992435886007005006006007005005006009001,0005005008005004003001,0005004006004001,4002,7003,5003,1003,2002,3002,6002,3001,3001,8002,4001,9001,2001,6001,3001,3001,10000000001000000000
   > Long-term Assets 
0
0
0
4,300
0
0
0
4,100
0
0
0
4,700
4,900
46,000
46,100
3,900
3,800
4,000
4,200
4,100
4,200
4,200
4,300
4,400
4,500
4,600
4,700
4,900
5,000
5,300
5,100
6,300
6,300
6,800
6,900
6,900
6,800
7,300
7,000
6,900
6,700
6,500
5,700
4,900
5,000
4,800
4,800
4,600
4,400
4,400
4,200
4,200
4,100
4,100
3,924
3,238
3,225
3,180
2,651
2,666
2,606
2,600
2,435
2,298
2,173
2,036
2,036
857
797
689
629
613
544
0
233
204
250
233
216
199
183
167
151
135
119
0
104
96
87
70
54
44
39
35
39
33
52
56
51
2,568
1,371
1,613
1,673
1,628
1,511
1,935
1,910
1,861
1,800
2,026
2,133
2,146
2,104
1,990
2,121
2,181
2,343
2,495
2,042
2,004
2,108
2,323
2,375
2,584
2,715
3,134
3,436
3,633
8,871
9,220
14,863
15,311
16,849
19,622
24,531
29,732
53,964
56,129
62,224
68,737
75,003
80,975
85,550
89,307
93,066
97,312
100,775
105,465
107,191
108,823
108,823107,191105,465100,77597,31293,06689,30785,55080,97575,00368,73762,22456,12953,96429,73224,53119,62216,84915,31114,8639,2208,8713,6333,4363,1342,7152,5842,3752,3232,1082,0042,0422,4952,3432,1812,1211,9902,1042,1462,1332,0261,8001,8611,9101,9351,5111,6281,6731,6131,3712,568515652333935394454708796104011913515116718319921623325020423305446136296897978572,0362,0362,1732,2982,4352,6002,6062,6662,6513,1803,2253,2383,9244,1004,1004,2004,2004,4004,4004,6004,8004,8005,0004,9005,7006,5006,7006,9007,0007,3006,8006,9006,9006,8006,3006,3005,1005,3005,0004,9004,7004,6004,5004,4004,3004,2004,2004,1004,2004,0003,8003,90046,10046,0004,9004,7000004,1000004,300000
       Property Plant Equipment 
0
0
0
900
0
0
0
1,000
0
0
0
1,900
2,200
12,100
13,800
2,100
2,100
2,300
2,400
2,500
2,600
2,800
2,900
3,000
2,900
3,000
3,000
3,000
3,200
3,500
3,700
2,900
4,800
5,300
5,500
5,600
5,500
5,300
5,200
5,100
5,000
4,900
4,700
4,600
4,600
4,500
4,400
4,300
4,200
4,100
4,000
4,000
4,000
3,900
3,750
3,039
3,027
2,928
2,382
2,422
2,340
2,300
2,137
2,004
1,879
1,750
1,750
582
562
477
409
417
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
6
5
5
4
6
6
5
4
4
3
2
294
248
221
177
139
109
111
111
114
382
543
597
613
619
583
664
830
971
1,295
1,260
1,321
1,494
1,484
1,643
1,764
2,197
2,377
2,476
7,673
8,039
13,699
13,907
15,361
18,107
22,933
28,072
52,167
54,075
59,896
66,277
71,963
78,116
82,360
85,963
89,618
93,663
96,917
101,417
102,903
104,292
104,292102,903101,41796,91793,66389,61885,96382,36078,11671,96366,27759,89654,07552,16728,07222,93318,10715,36113,90713,6998,0397,6732,4762,3772,1971,7641,6431,4841,4941,3211,2601,29597183066458361961359754338211411111110913917722124829423445664556700000000000000004174094775625821,7501,7501,8792,0042,1372,3002,3402,4222,3822,9283,0273,0393,7503,9004,0004,0004,0004,1004,2004,3004,4004,5004,6004,6004,7004,9005,0005,1005,2005,3005,5005,6005,5005,3004,8002,9003,7003,5003,2003,0003,0003,0002,9003,0002,9002,8002,6002,5002,4002,3002,1002,10013,80012,1002,2001,9000001,000000900000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
170
170
170
170
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000001701701701701700000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,521
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000002,521000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
100
0
0
0
200
0
0
0
200
200
31,200
28,000
200
200
200
200
200
200
200
200
200
200
1,300
1,500
300
300
300
300
900
900
800
800
700
700
600
600
600
500
500
400
400
300
300
300
300
300
300
200
200
200
200
169
199
198
252
269
244
265
300
299
293
294
286
286
275
235
212
220
196
57
51
51
42
98
91
84
78
71
65
59
54
48
43
43
55
50
44
38
39
34
30
33
28
47
53
48
45
907
899
911
885
737
574
590
583
580
570
568
579
576
577
597
609
635
678
747
743
788
829
891
941
951
937
1,058
1,158
1,198
1,181
1,164
1,404
1,488
1,515
1,598
1,660
1,797
2,054
2,328
2,460
2,701
2,859
3,190
3,344
3,448
3,649
3,858
4,048
4,288
4,531
4,5314,2884,0483,8583,6493,4483,3443,1902,8592,7012,4602,3282,0541,7971,6601,5981,5151,4881,4041,1641,1811,1981,1581,058937951941891829788743747678635609597577576579568570580583590574737885911899907454853472833303439384450554343485459657178849198425151571962202122352752862862942932993002652442692521981991692002002002003003003003003003004004005005006006006007007008008009009003003003003001,5001,30020020020020020020020020020020028,00031,200200200000200000100000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
646
0
648
1,076
1,365
1,451
1,452
1,372
1,826
1,799
1,751
1,686
1,643
1,591
1,549
1,491
1,371
1,538
1,517
1,513
1,524
747
743
788
829
891
941
951
937
1,058
1,158
1,198
0
0
0
0
0
0
0
0
1
0
141,795
339
0
0
2
0
0
0
0
0
0
000000200339141,79501000000001,1981,1581,0589379519418918297887437471,5241,5131,5171,5381,3711,4911,5491,5911,6431,6861,7511,7991,8261,3721,4521,4511,3651,07664806460000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1,300
0
0
0
1,100
0
0
0
1,700
1,900
51,600
51,100
1,500
1,500
1,500
1,800
700
1,000
700
800
500
700
700
900
700
1,200
1,300
1,000
1,600
1,700
1,700
1,700
1,500
1,700
1,900
1,900
1,400
1,300
1,500
2,300
3,000
3,400
2,000
1,900
1,600
1,900
2,200
2,300
2,600
2,700
2,700
3,943
3,755
4,112
4,918
4,784
3,881
3,190
3,100
2,891
3,231
3,017
3,183
3,183
2,724
2,774
2,844
2,465
2,465
2,518
521
521
185
225
161
178
195
175
218
252
204
214
201
201
234
208
211
258
417
269
5,747
468
137
141
114
232
612
6,483
6,424
6,357
6,567
8,489
23,060
23,857
24,972
25,650
27,548
28,261
29,575
30,283
27,646
28,816
28,953
29,737
29,350
28,658
28,958
29,669
31,439
31,148
31,457
31,676
33,693
33,479
10,040
12,178
13,191
19,749
18,643
18,781
22,490
20,689
50,201
72,224
78,232
77,665
91,829
94,690
95,474
94,174
94,394
94,075
94,388
91,961
94,489
96,820
101,162
101,16296,82094,48991,96194,38894,07594,39494,17495,47494,69091,82977,66578,23272,22450,20120,68922,49018,78118,64319,74913,19112,17810,04033,47933,69331,67631,45731,14831,43929,66928,95828,65829,35029,73728,95328,81627,64630,28329,57528,26127,54825,65024,97223,85723,0608,4896,5676,3576,4246,4836122321141411374685,7472694172582112082342012012142042522181751951781612251855215212,5182,4652,4652,8442,7742,7243,1833,1833,0173,2312,8913,1003,1903,8814,7844,9184,1123,7553,9432,7002,7002,6002,3002,2001,9001,6001,9002,0003,4003,0002,3001,5001,3001,4001,9001,9001,7001,5001,7001,7001,7001,6001,0001,3001,2007009007007005008007001,0007001,8001,5001,5001,50051,10051,6001,9001,7000001,1000001,300000
   > Total Current Liabilities 
0
0
0
700
0
0
0
700
0
0
0
600
800
50,100
49,600
700
700
800
1,100
700
1,000
800
800
500
700
600
900
600
1,200
1,200
900
1,400
1,500
1,600
1,600
1,300
1,600
1,700
1,700
1,200
1,100
1,300
2,100
2,800
3,200
1,800
1,700
1,400
1,800
2,000
2,100
2,400
2,500
2,500
3,746
3,724
4,087
4,080
3,950
3,022
2,338
2,900
2,798
2,948
2,760
3,173
3,173
2,717
2,708
2,782
2,405
2,407
2,518
521
521
185
225
161
178
195
175
218
252
204
214
201
201
234
208
211
258
417
269
5,747
468
137
141
114
232
612
1,657
2,020
2,425
3,106
3,749
1,480
1,419
1,588
1,317
2,098
1,923
2,253
2,034
2,445
3,437
3,422
4,100
3,709
3,765
3,922
4,595
11,081
10,695
10,952
11,138
13,719
15,567
9,857
12,015
13,044
16,492
16,233
16,757
20,880
19,488
14,018
18,792
22,831
22,273
21,628
23,359
24,293
22,945
23,600
23,547
23,753
21,238
23,933
26,646
30,430
30,43026,64623,93321,23823,75323,54723,60022,94524,29323,35921,62822,27322,83118,79214,01819,48820,88016,75716,23316,49213,04412,0159,85715,56713,71911,13810,95210,69511,0814,5953,9223,7653,7094,1003,4223,4372,4452,0342,2531,9232,0981,3171,5881,4191,4803,7493,1062,4252,0201,6576122321141411374685,7472694172582112082342012012142042522181751951781612251855215212,5182,4072,4052,7822,7082,7173,1733,1732,7602,9482,7982,9002,3383,0223,9504,0804,0873,7243,7462,5002,5002,4002,1002,0001,8001,4001,7001,8003,2002,8002,1001,3001,1001,2001,7001,7001,6001,3001,6001,6001,5001,4009001,2001,2006009006007005008008001,0007001,10080070070049,60050,100800600000700000700000
       Short-term Debt 
0
0
0
100
0
0
0
100
0
0
0
100
500
45,500
45,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
412
860
732
367
458
38
35
0
941
942
938
1,154
1,154
277
257
233
232
231
0
3
3
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
435
918
1,402
1,886
0
0
0
0
0
0
0
0
25,086
0
0
0
24,702
0
4,046
4,046
4,046
3,999
3,855
4,022
4,735
6,825
39
36
28
1,361
1,832
1,773
1,736
1,785
1,553
2,499
863
1,442
1,789
1,674
1,834
2,073
1,762
1,530
1,310
1,050
1,040
1,096
1,547
1,5471,0961,0401,0501,3101,5301,7622,0731,8341,6741,7891,4428632,4991,5531,7851,7361,7731,8321,3612836396,8254,7354,0223,8553,9994,0464,0464,046024,70200025,086000000001,8861,402918435000000000000000000000000303302312322332572771,1541,1549389429410353845836773286041200000000000000010010010000000000000000000000045,50045,500500100000100000100000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,086
0
0
0
24,702
0
4,046
4,046
21
3,999
24,169
22
735
2,810
84
0
28
1,361
1,832
0
1,736
1,785
1,553
0
863
0
0
0
0
0
0
0
0
0
0
0
0
00000000000086301,5531,7851,73601,8321,361280842,8107352224,1693,999214,0464,046024,70200025,08600000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
100
3,400
3,000
400
500
500
700
500
700
400
400
300
500
500
700
300
800
800
600
1,000
1,000
1,100
1,100
800
1,000
800
1,100
900
800
700
800
800
1,100
1,100
1,100
800
1,200
1,500
1,400
1,700
1,800
1,700
2,224
1,911
2,453
2,795
2,372
1,176
912
0
741
489
688
588
588
733
709
337
378
219
0
0
5
9
53
10
14
28
11
14
54
17
29
0
13
49
25
26
69
76
47
85
180
42
89
62
116
207
1,657
1,585
1,506
1,704
1,863
1,480
1,419
1,588
1,317
2,084
1,909
2,239
2,020
1,161
1,966
1,838
1,641
2,091
2,004
1,863
1,893
4,419
2,919
3,055
2,104
3,238
3,297
4,161
4,788
4,517
7,401
5,681
3,787
8,262
7,184
3,887
3,507
4,597
9,157
6,721
6,428
5,923
20,872
21,838
22,017
8,964
20,188
22,893
25,550
28,883
28,88325,55022,89320,1888,96422,01721,83820,8725,9236,4286,7219,1574,5973,5073,8877,1848,2623,7875,6817,4014,5174,7884,1613,2973,2382,1043,0552,9194,4191,8931,8632,0042,0911,6411,8381,9661,1612,0202,2391,9092,0841,3171,5881,4191,4801,8631,7041,5061,5851,65720711662894218085477669262549130291754141128141053950021937833770973358858868848974109121,1762,3722,7952,4531,9112,2241,7001,8001,7001,4001,5001,2008001,1001,1001,1008008007008009001,1008001,0008001,1001,1001,0001,0006008008003007005005003004004007005007005005004003,0003,400100000000000000
       Other Current Liabilities 
0
0
0
600
0
0
0
600
0
0
0
500
200
1,200
1,100
300
200
300
400
200
300
400
400
200
200
100
200
300
400
400
300
400
500
500
500
500
500
800
500
300
300
600
1,300
2,000
2,100
700
600
600
600
500
700
700
700
800
1,110
953
902
917
75
350
292
0
114
653
439
1,431
650
1,366
1,208
1,710
1,425
1,591
2,518
0
273
176
172
150
164
167
164
203
199
187
185
0
188
185
183
185
189
341
222
5,663
288
95
52
52
117
404
0
0
1,506
1,704
1,863
1,480
1,419
1,588
1,317
2,084
1,909
2,239
2,020
1,270
1,457
1,570
2,445
1,604
1,747
2,030
2,667
2,583
3,742
4,003
4,968
5,714
5,413
5,630
7,169
8,481
7,706
8,701
11,183
10,868
10,505
8,564
12,772
17,371
11,674
13,118
15,257
16,536
20,872
21,838
22,017
13,479
20,188
22,893
25,550
0
025,55022,89320,18813,47922,01721,83820,87216,53615,25713,11811,67417,37112,7728,56410,50510,86811,1838,7017,7068,4817,1695,6305,4135,7144,9684,0033,7422,5832,6672,0301,7471,6042,4451,5701,4571,2702,0202,2391,9092,0841,3171,5881,4191,4801,8631,7041,506004041175252952885,663222341189185183185188018518719920316416716415017217627302,5181,5911,4251,7101,2081,3666501,4314396531140292350759179029531,1108007007007005006006006007002,1002,0001,3006003003005008005005005005005004003004004003002001002002004004003002004003002003001,1001,200200500000600000600000
   > Long-term Liabilities 
0
0
0
600
0
0
0
400
0
0
0
1,100
1,100
1,500
1,500
800
800
700
700
500
700
-100
400
300
500
100
700
100
800
100
100
200
200
100
100
200
100
200
200
200
200
200
200
200
200
200
200
200
100
200
200
200
200
200
197
31
25
839
835
860
852
200
94
283
258
11
11
7
66
62
60
58
0
0
7
9
53
10
14
28
11
14
54
17
29
0
13
49
25
26
69
76
47
85
180
42
89
62
116
207
4,826
4,404
3,932
3,461
4,739
21,580
22,438
23,384
24,333
25,450
26,338
27,321
28,249
25,201
25,379
25,531
25,637
25,641
24,893
25,035
25,074
20,358
20,453
20,505
20,538
19,974
17,912
183
163
147
3,257
2,410
2,024
1,610
1,201
36,183
53,432
55,401
55,392
70,201
71,331
71,181
71,229
70,794
70,528
70,635
70,723
70,556
70,174
70,732
70,73270,17470,55670,72370,63570,52870,79471,22971,18171,33170,20155,39255,40153,43236,1831,2011,6102,0242,4103,25714716318317,91219,97420,53820,50520,45320,35825,07425,03524,89325,64125,63725,53125,37925,20128,24927,32126,33825,45024,33323,38422,43821,5804,7393,4613,9324,4044,8262071166289421808547766926254913029175414112814105397005860626671111258283942008528608358392531197200200200200200100200200200200200200200200200200200100200100100200200100100800100700100500300400-1007005007007008008001,5001,5001,1001,100000400000600000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,826
4,404
3,932
3,461
4,739
43,161
22,438
23,384
24,333
25,364
26,256
27,243
28,174
25,086
25,269
25,427
25,537
25,547
24,804
24,952
24,996
20,266
20,277
20,314
20,357
19,905
17,761
45
38
35
3,223
2,381
2,002
30
1,189
31,960
50,793
52,901
52,871
66,425
46,238
65,619
45,041
45,263
45,487
66,117
45,931
46,154
0
0
0046,15445,93166,11745,48745,26345,04165,61946,23866,42552,87152,90150,79331,9601,189302,0022,3813,22335384517,76119,90520,35720,31420,27720,26624,99624,95224,80425,54725,53725,42725,26925,08628,17427,24326,25625,36424,33323,38422,43843,1614,7393,4613,9324,4044,8260000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,670
0
2,608
0
0
0
0
0
0
0
0
0
86
82
79
75
116
110
105
99
94
88
83
78
92
177
190
181
69
151
138
125
112
34
29
22
15
12
4,223
189
3
2
0
0
0
0
0
0
0
0
0
0
0
00000000000231894,223121522293411212513815169181190177927883889499105110116757982860000000002,60802,6700000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86
82
79
75
115
110
105
99
94
88
83
78
92
177
191
181
69
0
0
0
0
0
0
0
0
0
0
0
2,497
2,519
3,776
3,822
5,562
5,310
4,876
4,407
4,518
4,703
4,271
0
0
004,2714,7034,5184,4074,8765,3105,5623,8223,7762,5192,4970000000000069181191177927883889499105110115757982860000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
5,400
0
0
0
5,800
0
0
0
6,500
6,600
6,600
6,400
6,900
6,800
6,900
7,200
7,700
8,000
8,800
9,000
9,400
9,700
9,700
10,000
10,300
10,700
10,900
11,000
10,800
10,900
11,000
11,200
11,200
11,200
10,500
10,700
10,900
11,100
10,800
9,300
8,800
9,000
10,300
10,100
9,700
9,300
8,400
8,000
7,500
6,900
6,100
5,494
4,720
4,122
3,442
2,898
6,087
4,896
0
2,752
1,987
1,625
967
967
332
-12
-154
-2
-51
1,221
0
2,282
1,600
1,524
1,664
1,612
1,506
1,444
1,297
1,184
1,033
918
0
899
562
434
313
179
318
187
11,061
10,854
10,650
10,264
10,029
11,138
11,549
7,958
6,071
4,120
3,271
1,205
-2,829
-6,005
-9,299
4,114
137
-3,693
-7,176
-10,186
-11,246
-680
-3,530
11,176
8,196
4,839
2,793
1,104
14,921
12,125
11,309
10,552
25,182
21,691
150,503
149,479
146,982
140,743
137,960
135,411
132,153
124,194
119,760
121,713
123,149
119,704
118,703
115,281
112,550
103,851
101,690
101,445
100,999
97,513
97,152
97,810
95,665
95,66597,81097,15297,513100,999101,445101,690103,851112,550115,281118,703119,704123,149121,713119,760124,194132,153135,411137,960140,743146,982149,479150,50321,69125,18210,55211,30912,12514,9211,1042,7934,8398,19611,176-3,530-680-11,246-10,186-7,176-3,6931374,114-9,299-6,005-2,8291,2053,2714,1206,0717,95811,54911,13810,02910,26410,65010,85411,06118731817931343456289909181,0331,1841,2971,4441,5061,6121,6641,5241,6002,28201,221-51-2-154-123329679671,6251,9872,75204,8966,0872,8983,4424,1224,7205,4946,1006,9007,5008,0008,4009,3009,70010,10010,3009,0008,8009,30010,80011,10010,90010,70010,50011,20011,20011,20011,00010,90010,80011,00010,90010,70010,30010,0009,7009,7009,4009,0008,8008,0007,7007,2006,9006,8006,9006,4006,6006,6006,5000005,8000005,400000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39
39
39
39
39
39
39
0
40
40
40
40
40
40
40
40
40
40
40
0
40
41
41
41
41
41
41
41
42
42
42
0
42
43
43
43
43
43
43
43
43
43
43
43
43
43
109
111
111
111
111
111
111
111
173
173
174
175
175
195
249
249
298
300
300
301
302
330
331
332
334
344
347
383
387
389
391
393
395
396
397
400
401
406
408
413
415
417
420
420
423
424
428
430
430
431
43143043042842442342042041741541340840640140039739639539339138938738334734433433233133030230130030029824924919517517517417317311111111111111111111110943434343434343434343434343420424242414141414141414004040404040404040404040039393939393939000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity00-273,314-266,654-259,580-254,165-249,847-242,107-230,632-225,346-218,205-210,307-203,647-197,637-196,158-188,0530-172,823-167,252-160,230-150,726-145,497-141,395-133,968-128,329-125,830-123,706-121,646-117,884-112,257-109,951-107,149-103,473-99,861-96,882-93,691-90,116-83,625-80,387-76,645-72,406-68,297-64,744-61,286-57,849-53,807-51,570-50,540-48,431-46,294-1,795000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-500
0
0
0
-800
0
0
0
-800
-800
-1,000
-1,300
-900
-1,000
-1,100
-1,100
-1,100
-1,200
-1,300
-1,300
-1,100
-1,500
-1,600
-1,700
-1,700
-1,900
-2,000
-2,100
-2,300
-2,400
-2,500
-2,700
-2,800
-3,000
-3,100
-3,300
-3,500
-3,700
-3,900
-4,100
-4,200
-4,400
-4,600
-4,800
-4,900
-5,100
-5,300
-5,500
-5,600
-5,800
-6,000
-12
5
5
-4,877
-4,583
-4,650
-4,650
0
-4,905
-4,905
-4,905
-5,430
-5,430
-5,430
0
-4,845
-4,845
-4,845
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-1
-2
-2
-3
-4
-5
-5
-6
-7
-7
-1,260
-1,319
-1,319
0
0
-1,502
-1,502
0
0
-1,582
-1,615
-1,649
-1,693
-1,735
-1,777
-1,823
-1,877
-1,938
-2,017
-2,106
-2,201
-1,801
-1,909
-2,019
-2,148
-2,289
-2,469
-2,664
-2,662
-2,861
-3,042
-3,270
-3,491
-3,764
-4,071
-4,382
-4,757
0
0
-6,230
0
0
0
0
0
0
0
0
0
0
0000000000-6,23000-4,757-4,382-4,071-3,764-3,491-3,270-3,042-2,861-2,662-2,664-2,469-2,289-2,148-2,019-1,909-1,801-2,201-2,106-2,017-1,938-1,877-1,823-1,777-1,735-1,693-1,649-1,615-1,58200-1,502-1,50200-1,319-1,319-1,260-7-7-6-5-5-4-3-2-2-1-100000000000000000-4,845-4,845-4,8450-5,430-5,430-5,430-4,905-4,905-4,9050-4,650-4,650-4,583-4,87755-12-6,000-5,800-5,600-5,500-5,300-5,100-4,900-4,800-4,600-4,400-4,200-4,100-3,900-3,700-3,500-3,300-3,100-3,000-2,800-2,700-2,500-2,400-2,300-2,100-2,000-1,900-1,700-1,700-1,600-1,500-1,100-1,300-1,300-1,200-1,100-1,100-1,100-1,000-900-1,300-1,000-800-800000-800000-500000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,301
54,143
54,392
54,550
54,730
54,901
54,908
55,170
55,334
72,238
72,369
72,778
73,036
73,264
78,676
92,762
93,103
110,739
111,368
111,688
112,443
113,058
132,475
133,440
134,683
136,048
153,168
155,312
291,515
294,589
297,319
300,582
304,819
307,839
311,618
311,850
315,518
318,949
326,390
329,603
336,495
340,212
342,765
345,538
351,117
355,187
360,155
363,739
370,036
0
0
00370,036363,739360,155355,187351,117345,538342,765340,212336,495329,603326,390318,949315,518311,850311,618307,839304,819300,582297,319294,589291,515155,312153,168136,048134,683133,440132,475113,058112,443111,688111,368110,73993,10392,76278,67673,26473,03672,77872,36972,23855,33455,17054,90854,90154,73054,55054,39254,14313,301000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
4,600
0
0
0
4,400
0
0
0
4,400
4,300
4,500
4,800
4,500
4,300
4,300
4,300
4,600
4,700
5,400
5,300
6,900
7,300
7,400
7,600
9,500
9,700
12,300
10,600
12,000
12,200
12,300
12,500
12,800
13,100
13,200
13,400
13,800
14,200
14,400
14,500
14,700
14,900
16,400
16,700
16,700
16,700
16,600
16,800
16,900
17,100
17,300
11,289
11,316
11,316
11,333
11,333
11,344
11,343
0
16,285
16,286
16,295
16,820
16,820
16,978
11,548
16,396
16,473
16,414
11,670
0
11,689
11,923
11,848
11,848
11,848
11,848
11,848
11,848
11,849
11,856
12,198
0
12,198
12,197
12,652
12,653
12,653
12,654
12,655
12,655
12,695
11,088
11,167
12,943
13,147
13,308
55,403
55,710
54,550
54,730
54,901
56,411
55,170
55,334
72,238
73,951
74,394
74,686
74,957
80,411
94,539
94,925
112,616
113,307
113,705
114,549
115,260
134,276
135,349
136,702
138,196
155,457
157,781
294,179
297,251
300,180
303,624
308,089
311,330
315,382
311,850
315,518
318,949
326,390
329,603
336,495
340,212
342,765
345,538
351,117
355,187
360,155
363,739
370,036
374,783
376,530
376,530374,783370,036363,739360,155355,187351,117345,538342,765340,212336,495329,603326,390318,949315,518311,850315,382311,330308,089303,624300,180297,251294,179157,781155,457138,196136,702135,349134,276115,260114,549113,705113,307112,61694,92594,53980,41174,95774,68674,39473,95172,23855,33455,17056,41154,90154,73054,55055,71055,40313,30813,14712,94311,16711,08812,69512,65512,65512,65412,65312,65312,65212,19712,198012,19811,85611,84911,84811,84811,84811,84811,84811,84811,92311,689011,67016,41416,47316,39611,54816,97816,82016,82016,29516,28616,285011,34311,34411,33311,33311,31611,31611,28917,30017,10016,90016,80016,60016,70016,70016,70016,40014,90014,70014,50014,40014,20013,80013,40013,20013,10012,80012,50012,30012,20012,00010,60012,3009,7009,5007,6007,4007,3006,9005,3005,4004,7004,6004,3004,3004,3004,5004,8004,5004,3004,4000004,4000004,600000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue159,012
Cost of Revenue-31,138
Gross Profit127,874127,874
 
Operating Income (+$)
Gross Profit127,874
Operating Expense-149,336
Operating Income-21,462-21,462
 
Operating Expense (+$)
Research Development28,333
Selling General Administrative34,943
Selling And Marketing Expenses86,060
Operating Expense149,336149,336
 
Net Interest Income (+$)
Interest Income0
Interest Expense-8,120
Other Finance Cost-7,168
Net Interest Income-952
 
Pretax Income (+$)
Operating Income-21,462
Net Interest Income-952
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-21,716-21,208
EBIT - interestExpense = -29,582
-21,716
-13,596
Interest Expense8,120
Earnings Before Interest and Taxes (EBIT)-21,462-13,596
Earnings Before Interest and Taxes (EBITDA)-15,909
 
After tax Income (+$)
Income Before Tax-21,716
Tax Provision-0
Net Income From Continuing Ops-23,238-21,716
Net Income-21,716
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses180,474
Total Other Income/Expenses Net-254952
 

Technical Analysis of Axogen Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Axogen Inc. The general trend of Axogen Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Axogen Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Axogen Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7.3126 < 8.25 < 9.45.

The bearish price targets are: 6.69 > 6.52 > 4.71.

Tweet this
Axogen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Axogen Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Axogen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Axogen Inc.

Axogen Inc Daily Moving Average Convergence/Divergence (MACD) ChartAxogen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Axogen Inc. The current adx is .

Axogen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Axogen Inc.

Axogen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Axogen Inc.

Axogen Inc Daily Relative Strength Index (RSI) ChartAxogen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Axogen Inc.

Axogen Inc Daily Stochastic Oscillator ChartAxogen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Axogen Inc.

Axogen Inc Daily Commodity Channel Index (CCI) ChartAxogen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Axogen Inc.

Axogen Inc Daily Chande Momentum Oscillator (CMO) ChartAxogen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Axogen Inc.

Axogen Inc Daily Williams %R ChartAxogen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Axogen Inc.

Axogen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Axogen Inc.

Axogen Inc Daily Average True Range (ATR) ChartAxogen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Axogen Inc.

Axogen Inc Daily On-Balance Volume (OBV) ChartAxogen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Axogen Inc.

Axogen Inc Daily Money Flow Index (MFI) ChartAxogen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Axogen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Axogen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Axogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.450
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Axogen Inc with someone you think should read this too:
  • Are you bullish or bearish on Axogen Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Axogen Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Axogen Inc

I send you an email if I find something interesting about Axogen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Axogen Inc.

Receive notifications about Axogen Inc in your mailbox!